Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
637M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
188M
-
Shares change
-
-4.42M
-
Total reported value, excl. options
-
$441M
-
Value change
-
-$9.35M
-
Put/Call ratio
-
0.16
-
Number of buys
-
93
-
Number of sells
-
-40
-
Price
-
$2.34
Significant Holders of GERON CORP - Common Stock, $0.001 par value (GERN) as of Q3 2022
192 filings reported holding GERN - GERON CORP - Common Stock, $0.001 par value as of Q3 2022.
GERON CORP - Common Stock, $0.001 par value (GERN) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 188M shares
of 637M outstanding shares and own 29.58% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (30.1M shares), BlackRock Inc. (26.6M shares), VANGUARD GROUP INC (18.2M shares), NEA Management Company, LLC (16.3M shares), Vivo Capital, LLC (15.2M shares), STATE STREET CORP (13.5M shares), TCG Crossover Management, LLC (12.1M shares), BIOIMPACT CAPITAL LLC (8.42M shares), GEODE CAPITAL MANAGEMENT, LLC (6.18M shares), and NORTHERN TRUST CORP (3.51M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.